These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 8621746

  • 1. Positron emission tomographic imaging of serotonin activation effects on prefrontal cortex in healthy volunteers.
    Mann JJ, Malone KM, Diehl DJ, Perel J, Nichols TE, Mintun MA.
    J Cereb Blood Flow Metab; 1996 May; 16(3):418-26. PubMed ID: 8621746
    [Abstract] [Full Text] [Related]

  • 2. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression.
    Oquendo MA, Placidi GP, Malone KM, Campbell C, Keilp J, Brodsky B, Kegeles LS, Cooper TB, Parsey RV, van Heertum RL, Mann JJ.
    Arch Gen Psychiatry; 2003 Jan; 60(1):14-22. PubMed ID: 12511168
    [Abstract] [Full Text] [Related]

  • 3. Regional brain responses to serotonin in major depressive disorder.
    Anderson AD, Oquendo MA, Parsey RV, Milak MS, Campbell C, Mann JJ.
    J Affect Disord; 2004 Nov 01; 82(3):411-7. PubMed ID: 15555692
    [Abstract] [Full Text] [Related]

  • 4. Regional brain glucose uptake distinguishes suicide attempters from non-attempters in major depression.
    Sublette ME, Milak MS, Galfalvy HC, Oquendo MA, Malone KM, Mann JJ.
    Arch Suicide Res; 2013 Nov 01; 17(4):434-47. PubMed ID: 24224676
    [Abstract] [Full Text] [Related]

  • 5. A fenfluramine-activated FDG-PET study of borderline personality disorder.
    Soloff PH, Meltzer CC, Greer PJ, Constantine D, Kelly TM.
    Biol Psychiatry; 2000 Mar 15; 47(6):540-7. PubMed ID: 10715360
    [Abstract] [Full Text] [Related]

  • 6. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients.
    Mann JJ, Malone KM, Diehl DJ, Perel J, Cooper TB, Mintun MA.
    Am J Psychiatry; 1996 Feb 15; 153(2):174-82. PubMed ID: 8561196
    [Abstract] [Full Text] [Related]

  • 7. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorder.
    Oquendo MA, Krunic A, Parsey RV, Milak M, Malone KM, Anderson A, van Heertum RL, John Mann J.
    Neuropsychopharmacology; 2005 Jun 15; 30(6):1163-72. PubMed ID: 15770239
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modulation of cortical neuronal activity by a serotonergic agent: a PET study in humans.
    Kapur S, Meyer J, Wilson AA, Houle S, Brown GM.
    Brain Res; 1994 May 23; 646(2):292-4. PubMed ID: 8069675
    [Abstract] [Full Text] [Related]

  • 10. Gender differences in a fenfluramine-activated FDG PET study of borderline personality disorder.
    Soloff PH, Meltzer CC, Becker C, Greer PJ, Constantine D.
    Psychiatry Res; 2005 Apr 30; 138(3):183-95. PubMed ID: 15854787
    [Abstract] [Full Text] [Related]

  • 11. No effect of depression on [(15)O]H2O PET response to intravenous d-fenfluramine.
    Meyer JH, Kennedy S, Brown GM.
    Am J Psychiatry; 1998 Sep 30; 155(9):1241-6. PubMed ID: 9734549
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorder.
    Evans KC, Simon NM, Dougherty DD, Hoge EA, Worthington JJ, Chow C, Kaufman RE, Gold AL, Fischman AJ, Pollack MH, Rauch SL.
    Neuropsychopharmacology; 2009 Jan 30; 34(2):390-8. PubMed ID: 18536708
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse.
    Bremner JD, Innis RB, Salomon RM, Staib LH, Ng CK, Miller HL, Bronen RA, Krystal JH, Duncan J, Rich D, Price LH, Malison R, Dey H, Soufer R, Charney DS.
    Arch Gen Psychiatry; 1997 Apr 30; 54(4):364-74. PubMed ID: 9107153
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.